EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte Studie

HLA selected red cell transfusions to prevent HLA sensitisation: a prospective, double-blinded, randomised controlled trial

Jeremy S McComish, Jessica Brewster, Christian P Brizard, Emma Carreiro, Christopher Hogan, Raymond Hu, Irene Ng, Sanjoy Paul, Daryl Williams, Daniela Zantomio, James Daly

Transplant Immunology · 2026-08 · 97 · 102412

DOI: 10.1016/j.trim.2026.102412 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Transplant Immunology, 2026-08. Verfasst von Jeremy S McComish und 10 weiteren Autor:innen. Beteiligte Einrichtung: Australian Red Cross Lifeblood, Melbourne, Australia. Electronic address: jmccomish@redcrossblood.org.au. Hauptthemen laut MEDLINE: HLA Antigens, Erythrocyte Transfusion. Die Arbeit nennt 31 Literaturangaben. Gefördert von: Australian Red Cross Lifeblood, National Blood Authority Australia.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Human Leucocyte Antigen (HLA) sensitisation following red cell transfusion can disrupt planned transplantation and impair outcomes. We conducted a prospective, randomised controlled, double blinded, parallel arm study to evaluate the efficacy of HLA selected red cell transfusions in preventing blood donor specific HLA antibodies (bDSA). Participants were recruited to two groups: adults requiring transfusion or surgery, and paediatric cardiac surgery patients; and randomised to receive red cells selected for HLA compatibility from HLA-typed blood donors, or unselected red cells. Exclusion criteria included recent transfusions, immunoglobulin or B cell depleting treatments, and requirement for additional blood products. The primary outcome was cumulative incidence of de novo bDSA, by HLA antibody testing pre- and post-transfusion. 73 adult participants and 68 paediatric participants were randomised, with 26 and 52 respectively completing the study. Many randomised participants (40% and 59% in adult and paediatric groups respectively) received non-trial products, and there was no significant difference between treatment groups in the intention-to-treat analyses. No de novo bDSA were detected in participants who had received trial products only, while de novo bDSA were detected in participants who received unselected red cell products. Larger studies could confirm the potential to avoid HLA sensitisation by blood donor selection.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HLA AntigensErythrocyte TransfusionHumansFemaleProspective StudiesAdultMaleChildIsoantibodiesDouble-Blind MethodMiddle AgedHistocompatibility TestingAdolescentChild, PreschoolBlood Donors

Stichwörter der Autor:innen

AllosensitisationCompatibilityHLA antibodiesTransfusions

Substanzen

HLA AntigensIsoantibodies

Autor:innen und Institutionen

  • Australian Red Cross Lifeblood, Melbourne, Australia. Electronic address: jmccomish@redcrossblood.org.au.
  • Australian Red Cross Lifeblood, Melbourne, Australia.
  • Cardiac Surgery Unit, Royal Children's Hospital, Melbourne, Australia.
  • Austin Health, Melbourne, Australia.
  • Department of Critical Care, The University of Melbourne, Melbourne, Australia; Department of Anaesthesia, Austin Health, Melbourne, Australia.
  • Department of Critical Care, The University of Melbourne, Melbourne, Australia; Department of Anaesthesia & Pain Management, Royal Melbourne Hospital, Melbourne, Australia.

Förderung

  • Australian Red Cross Lifeblood
  • National Blood Authority Australia

Zitieren

APA

McComish, J. S., Brewster, J., Brizard, C. P., Carreiro, E., Hogan, C., Hu, R., Ng, I., Paul, S., Williams, D., Zantomio, D., & Daly, J. (2026). HLA selected red cell transfusions to prevent HLA sensitisation: a prospective, double-blinded, randomised controlled trial. Transplant Immunology, 97, 102412. https://doi.org/10.1016/j.trim.2026.102412

Vancouver

McComish JS, Brewster J, Brizard CP, Carreiro E, Hogan C, Hu R, et al. HLA selected red cell transfusions to prevent HLA sensitisation: a prospective, double-blinded, randomised controlled trial. Transplant Immunology. 2026;97:102412. doi:10.1016/j.trim.2026.102412

BibTeX
@article{McComish2026,
  author = {McComish, Jeremy S and Brewster, Jessica and Brizard, Christian P and Carreiro, Emma and Hogan, Christopher and Hu, Raymond and Ng, Irene and Paul, Sanjoy and Williams, Daryl and Zantomio, Daniela and Daly, James},
  title = {HLA selected red cell transfusions to prevent HLA sensitisation: a prospective, double-blinded, randomised controlled trial},
  journal = {Transplant Immunology},
  year = {2026},
  volume = {97},
  pages = {102412},
  doi = {10.1016/j.trim.2026.102412}
}
Kostenlos starten →